A Phase I Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Phase of Trial: Phase I
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Belinostat (Primary) ; Warfarin (Primary)
- Indications Haematological malignancies; Solid tumours; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Spectrum Pharmaceuticals
- 22 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Mar 2015 Planned End Date changed from 1 Mar 2014 to 1 Aug 2015 as per ClinicalTrials.gov record.
- 19 Mar 2015 Planned primary completion date changed from 1 Mar 2014 to 1 May 2015 as per ClinicalTrials.gov record.